ct

Recent in North America (page 1 of 10)

US FDA Pushes Sunscreen Reform on Three Fronts

The U.S. Food and Drug Administration has announced three new efforts to advance its framework for sun protection products including Maximal Usage Trials (MUsT)—just ahead of summer vacation and in line with #DontFryDay.

U.S. FDA Investigates B. cepacian Complex Outbreak Linked to Personal Care

A no-rinse foam cleanser has been linked to at least 10 confirmed cases of Burkholderia cepacia complex; Shadow Holdings dba Bocchi Laboratories has voluntarily recalled the product as the FDA investigates.

Hawaii to Ban Certain Sunscreen Chemicals

Legislation was passed by the Hawaii state senate that, if signed by the governor, would prohibit the sale of sunscreen products containing certain ingredients. This move was in response to research showing their potential damage to coral reefs.

ICMAD Confirms Support of Cosmetic Ingredient Review

ICMAD, along with its more than 900-member companies, has announced their support of the efforts of the Cosmetic Ingredient Review (CIR) Expert Panel and the statement issued by its executive director Bart Heldreth, Ph.D., that the claims laid out by Women’s Voices for the Earth are erroneous

FDA to Hold Public Meeting In Preparation of ICCR Meeting

Information gathered from the public meeting will help the FDA prepare for the International Cooperation on Cosmetics Regulation-12 (ICCR-12) meeting to be held July 10-12, 2018, in Tokyo, Japan.

FDA Updates CFSAN Education Resource Library

Designed for personal and professional use, the library covers cosmetic safety, dietary supplements, food safety, nutrition and industry information such as food defense.

ICMAD President and CEO Releases Statement on Modernization of Cosmetics Regulation Act of 2018

ICMAD president and CEO Pam Busiek notes that the organization has begun reviewing the draft legislation, and will provide feedback by the deadline.

Legislation Proposed in Wake of Asbestos Allegations

New legislation has been proposed to the U.S. House of Representatives after children's and tween's product retailer Claire's recalled several cosmetic products thought to contain asbestos.

The Body Shop Urges Canadian Animal Testing Ban

The Canadian government is currently reviewing a ban on cosmetic animal testing, and is being lobbied by consumer brand The Body Shop.

FDA Begins Expediting Recall Information

The agency is increasing transparency in the product recall process.

FDA Sets Regulatory Framework for Regenerative Biological Therapies

It's a sign of the times when technology and innovation hit a point where the U.S. Food and Drug Administration must stop and write new rules to ensure consumer safety. That time, with respect to regenerative biological therapies, is now.

Canada’s ‘High’ Hopes for Regulatory Reform: Cannabis Legislation Sparks Debate

Canada is preparing for a regulatory overhaul that could replace outdated rules and classifications with one category:"Consumer Health Products." Cannabis-containing products also face trailblazing reform as countries and states disagree on the controversial ingredient's legality. What parallels can be drawn? Read on to learn.

Can't find what you're looking for? Try searching, or looking through past issues.